Safety and Efficacy of Ibutilide in Heart Transplant Recipients

José A. Tallaj; Veronica Franco; Barry K. Rayburn; Salpy V. Pamboukian; Raymond L. Benza; James K. Kirklin; David C. McGiffin; Melissa Smallfield; Robert C. Bourge

doi:10.1016/j.healun.2009.02.013

Safety and Efficacy of Ibutilide in Heart Transplant Recipients

José A. Tallaj, Veronica Franco, Barry K. Rayburn, Salpy V. Pamboukian, Raymond L. Benza, James K. Kirklin, David C. McGiffin, Melissa Smallfield, Robert C. Bourge

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)

Abstract

In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.

Original language	English
Pages (from-to)	505-507
Number of pages	3
Journal	The Journal of Heart and Lung Transplantation
Volume	28
Issue number	5
DOIs	https://doi.org/10.1016/j.healun.2009.02.013
Publication status	Published - 1 May 2009
Externally published	Yes

Access to Document

10.1016/j.healun.2009.02.013

Cite this

@article{c29937a56fe54c8da72c1451463a4287,

title = "Safety and Efficacy of Ibutilide in Heart Transplant Recipients",

abstract = "In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.",

author = "Tallaj, \{Jos{\'e} A.\} and Veronica Franco and Rayburn, \{Barry K.\} and Pamboukian, \{Salpy V.\} and Benza, \{Raymond L.\} and Kirklin, \{James K.\} and McGiffin, \{David C.\} and Melissa Smallfield and Bourge, \{Robert C.\}",

year = "2009",

month = may,

day = "1",

doi = "10.1016/j.healun.2009.02.013",

language = "English",

volume = "28",

pages = "505--507",

journal = "The Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Safety and Efficacy of Ibutilide in Heart Transplant Recipients

AU - Tallaj, José A.

AU - Franco, Veronica

AU - Rayburn, Barry K.

AU - Pamboukian, Salpy V.

AU - Benza, Raymond L.

AU - Kirklin, James K.

AU - McGiffin, David C.

AU - Smallfield, Melissa

AU - Bourge, Robert C.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.

AB - In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.

UR - https://www.scopus.com/pages/publications/65349158696

U2 - 10.1016/j.healun.2009.02.013

DO - 10.1016/j.healun.2009.02.013

M3 - Article

C2 - 19416781

AN - SCOPUS:65349158696

SN - 1053-2498

VL - 28

SP - 505

EP - 507

JO - The Journal of Heart and Lung Transplantation

JF - The Journal of Heart and Lung Transplantation

IS - 5

ER -

Safety and Efficacy of Ibutilide in Heart Transplant Recipients

Abstract

Access to Document

Other files and links

Cite this